20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9579L | GLP-1 receptor agonist 9 citrate | GLP-1 receptor agonist 9 citrate (2401892-71-3 Free base) | Glucagon Receptor |
GLP-1 receptor agonist 9 citrate is an agonist of GLP-1. | |||
T9579 | GLP-1 receptor agonist 9 | Glucagon Receptor | |
1H-Benzimidazole-6-carboxylic acid is a GLP-1 receptor agonist. | |||
T11408 | Orforglipron | LY3502970,GLP-1 receptor agonist 1 | Glucagon Receptor |
Orforglipron (LY3502970; GLP-1 receptor agonist 1) is an orally available glucagon-like peptide (GLP-1) receptor agonist for the study of obesity and type 1 diabetes in adults. | |||
T11407 | GLP-1 receptor agonist 2 | Others | |
GLP-1 receptor agonist 2 is a glucagon-like peptide-1 receptor (GLP-1R) agonist. | |||
T11404 | GLP-1 receptor agonist 3 | Others | |
GLP-1 receptor agonist 3 is a GLP-1 receptor agonist,Example 4A-1, has EC50s of 1.1 nM and 13 nM in Clone H6 and Clone C6 cell lines assay, respectively. | |||
T11405 | GLP-1 receptor agonist 4 | Others | |
GLP-1 receptor agonist 4 is a glucagon-like peptide-1 receptor (GLP-1R) agonist , has an EC50 of 64.5 nM. GLP-1 receptor agonist 4 can be used in the research for treatment of diabetes. | |||
T79348 | GLP-1 receptor agonist 13 | ||
Compound (S)-9, a GLP-1 receptor agonist, exhibits an EC50 of 76 nM for the glucagon GLP-1 receptor [1]. | |||
T74132 | GLP-1 receptor agonist 8 | ||
GLP-1 receptor agonist 8, a potent agonist of GLP-1 R, holds potential for diabetes, obesity, and nonalcoholic fatty liver disease (NAFLD) research[1]. | |||
T64195 | GLP-1 receptor agonist 7 | ||
GLP-1 receptor agonist 7 is a potent glucagon-like peptide-1 (GLP-1) agonist and has shown research potential for GLP-1 related diseases, disorders and conditions, including diabetes. | |||
T75150 | GIP/GLP-1 dual receptor agonist-1 | ||
GIP/GLP-1 dual receptor agonist-1 (compound 4), a receptor agonist for both GIP and GLP-1, shows potential for the research of metabolic disorders and fatty liver diseases, such as nonalcoholic steatohepatitis (NASH) and... | |||
T36579 | GLP-1R Agonist DMB | Glucagon Receptor | |
GLP-1R Agonist DMB is an agonist of glucagon-like peptide 1 receptor (GLP-1R; KB = 26.3 nM for the recombinant human receptor). | |||
TQ0124 | BETP | Glucagon Receptor | |
BETP is an agonist of GLP-1 receptor (EC50s: 0.66 and 0.755 μM for human and rat GLP-1 receptor). | |||
T8355 | Exenatide | Exendin-4,Extendin-4 | Glucagon Receptor |
Exenatide (Extendin-4) is a glucagon-like protein-1 (GLP-1) receptor agonist. | |||
TP1111L | Tirzepatide Acetate(2023788-19-2 free base) | Glucagon Receptor | |
Tirzepatide acetate is a dual GIP / GLP-1 receptor agonist. | |||
T76559 | Survodutide | BI 456906 | Glucagon Receptor |
Survodutide (BI 456906) is a dual agonist of glucagon and glucagon-like peptide 1 (GLP-1) receptor (GLP Receptor) that reduces body weight in HbA1c16 diabetes. | |||
TP1976L | Oxyntomodulin acetate | Glucagon Receptor | |
Oxyntomodulin acetate, a 37-amino acid peptide hormone, is a glucagon-like peptide 1 (GLP-1) receptor agonist[1]. | |||
T19850L | Semaglutide Acetate | Semaglutide Acetate(910463-68-2 Free base) | Glucagon Receptor |
Semaglutide Acetate is an agonist of a glucagon-like peptide 1 (GLP-1) receptor and can be used in studies about the treatment of type 2 diabetes. | |||
T12431 | PF-06882961 | Glucagon Receptor | |
PF-06882961 is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. | |||
T6876 | Liraglutide | Liraglutidum,Victoza,Liraglutida,NN2211 | Glucagon Receptor |
Liraglutide (Liraglutida) is a long-acting GLP-1 receptor agonist. | |||
T8876 | PF-06882961 Tris | UNII-2HJV78O0SS | Glucagon Receptor |
PF-06882961 Tris (UNII-2HJV78O0SS) is an orally bioavailable glucagon-like peptide-1 receptor (GLP-1R) agonist. |